Navigation Links
German Patient Surpasses 5 Years of Support on DuraHeart™ Left Ventricular Assist Device
Date:7/19/2011

s. Gieseke is a prime example of how someone who was in declining health can lead a fulfilling life with end stage heart failure."

The DuraHeart LVAS is the latest-generation rotary blood pump designed for long-term patient support.  The system incorporates a centrifugal flow rotary pump with the magnetically levitated impeller. The pump features three position sensors and electromagnetic coils that suspend the impeller inside the pump chamber without a single contact point. The impeller's active magnetic levitation is designed to eliminate friction by allowing a wide gap between blood contacting surfaces, enabling blood to flow through the pump unimpeded in a smooth, non-turbulent fashion.

The DuraHeart LVAS carries a CE Mark and is currently available for sale in Japan and Europe.  DuraHeart is limited to investigational use only in the United States.  For more information about heart failure, Ventricular Assist Devices or the DuraHeart LVAS, visit www.terumoheart.com.

About Heart Failure

More than 22 million people suffer from heart failure worldwide with approximately one million new patients diagnosed annually. In the setting of an aging global population, heart failure is the number one reason for hospitalization.  The most severely ill patients need heart transplants in order to recover. More than 8,000 people worldwide are on the list of eligible candidates for heart transplants annually, but less than 3,000 receive a transplant each year.  A large number of people who suffer from severe heart failure do not qualify for transplantation due to other health issues. An alternative for these patients is access to artificial mechanical assist.

About Terumo Heart, Inc.

Terumo Heart, Inc. is a U.S. subsidiary of Terumo Corporation with headquarters and manufacturing facilities in Ann Arbor, Michigan.  The company's focus is t
'/>"/>

SOURCE Terumo Heart, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Genzyme and Bayer Schering Pharma AG, Germany Announce Start of Phase 3 Program with Alemtuzumab for Treatment of Multiple Sclerosis
2. Kiadis Pharma Announces Collaboration With the Julius Maximilians University of Wurzburg, Germany
3. Helix Receives Approval to Open Sites in Germany for its Ongoing Clinical Trial With Topical Interferon Alpha-2b in Patients With Ano-Genital Warts
4. German Innovation for HIV/AIDS Diagnostics has Been Used 2.5 Million Times in 2008
5. STALLERGENES: Oralair(R) Grasses Obtains a Pediatric MA(1) in Germany
6. Award-Winning Medical Technology From Germany
7. BioStorage Technologies, Inc., Accelerates European Expansion with Opening of New German Facility
8. Enigma Diagnostics Showcases Its Unique Fully Automated rtPCR Based ML (Mini-Laboratory) Instrument For Point-of-Care Testing at MEDICA 2009 In Dusseldorf, Germany
9. Tekia Enters Into Distribution Agreement With Fritz Ruck/T-MED, Germany to Market Its Accommodative Intraocular Lens to Treat Presbyopia
10. Dune Medical Devices Announces Positive Interim Results From EU MarginProbe™ Study Presented at German Breast Cancer Society Meeting
11. German District Court Finds RENASYS™ GO NPWT System Non-infringing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... 28, 2015 This report analyzes the worldwide markets ... the following Segments: Standard Intraocular Lenses, and Premium Intraocular Lenses. ... Canada , Japan , ... Latin America , and Rest of World. Annual ... 2020. Also, a seven-year historic analysis is provided for these ...
(Date:5/28/2015)... , May 28, 2015 Isis Pharmaceuticals, ... , Akcea Therapeutics WebcastWhen: , Thursday, June 4 at ... www.isispharm.com How: , Live on the Internet.  Simply log ... to participate during the live event, a replay of ... at www.isispharm.com . ABOUT ISIS PHARMACEUTICALS, ...
(Date:5/28/2015)... 2015   Lexicon Pharmaceuticals, Inc. (Nasdaq: ... at the Jefferies 2015 Healthcare Conference on Wednesday, June ... New York .  Lexicon management will provide ... A webcast of the presentation will be ... archived version of the presentation will be available at ...
Breaking Medicine Technology:World Intraocular Lenses Industry 2World Intraocular Lenses Industry 3World Intraocular Lenses Industry 4World Intraocular Lenses Industry 5World Intraocular Lenses Industry 6World Intraocular Lenses Industry 7World Intraocular Lenses Industry 8World Intraocular Lenses Industry 9World Intraocular Lenses Industry 10World Intraocular Lenses Industry 11World Intraocular Lenses Industry 12World Intraocular Lenses Industry 13World Intraocular Lenses Industry 14World Intraocular Lenses Industry 15World Intraocular Lenses Industry 16World Intraocular Lenses Industry 17World Intraocular Lenses Industry 18World Intraocular Lenses Industry 19World Intraocular Lenses Industry 20World Intraocular Lenses Industry 21World Intraocular Lenses Industry 22World Intraocular Lenses Industry 23World Intraocular Lenses Industry 24World Intraocular Lenses Industry 25World Intraocular Lenses Industry 26Webcast Alert: Akcea Therapeutics Conference Call 2Webcast Alert: Akcea Therapeutics Conference Call 3Lexicon To Present At The Jefferies 2015 Healthcare Conference 2
... BARCELONA, Spain , June 1 Clinicians at Institut Catala ... in Spain using RapidArc® radiotherapy from Varian Medical Systems (NYSE: ... the first patient in the country to receive the fast and efficient ... "The treatment went ...
... BEIJING , June 1 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: ... it has received,the confirmation from the China International Tendering Company that Sinovac,was ... supply the Company,s hepatitis A vaccine, Healive, to the,Beijing Expanded Program of ... ...
Cached Medicine Technology:Prostate Cancer Patient First in Spain to Receive Fast and Precise RapidArc(R) Radiotherapy Treatment from Varian 2Prostate Cancer Patient First in Spain to Receive Fast and Precise RapidArc(R) Radiotherapy Treatment from Varian 3Prostate Cancer Patient First in Spain to Receive Fast and Precise RapidArc(R) Radiotherapy Treatment from Varian 4Sinovac Selected by Beijing CDC to Supply Hepatitis A Vaccine Healive(R) 2Sinovac Selected by Beijing CDC to Supply Hepatitis A Vaccine Healive(R) 3
(Date:5/29/2015)... (PRWEB) May 29, 2015 Mediaplanet has ... “beauty of protection”. Skin Health is a cross-platform ... within the markets of New York, Los Angeles, and ... 750,000 readers. Its digital counterpart will reach a national ... To read more the Skin Health campaign and Colorescience, ...
(Date:5/29/2015)... Dallas, TX (PRWEB) May 29, 2015 ... H1 2015” provides comprehensive information on the therapeutic ... different types of muscles in the body, leading ... strengthens R&D pipelines by identifying new targets and ... report on H1 2015 pipeline review of Axillary ...
(Date:5/29/2015)... Designed with the versatile athlete in mind, BPI ... new, exclusive line of supplementation called The 24/7 Series. ... greatest, high impact, result driven ingredients that have been ... Series can be used by anyone from bodybuilders to ... enthusiasts. There are no stimulant based ingredients that cause ...
(Date:5/29/2015)... The annual aesthetic meeting, put on by ... in Montreal from May 14-19th. This global event sets ... around the world; dedicating itself exclusively to cosmetic medicine. ... plastic surgeons to attend this year’s meeting. , Among ... Vitenas was given the honor of sitting at the presenter’s ...
(Date:5/29/2015)... Dallas, TX (PRWEB) May 29, 2015 ... Pipeline Review, H1 2015” provides comprehensive information ... The report strengthens R&D pipelines by identifying ... and best-in-class products. Complete report on H1 ... 18 market data tables and 13 figures, ...
Breaking Medicine News(10 mins):Health News:Mediaplanet Launches “Skin Health” Campaign Featuring Colorescience 2Health News:Muscle Spasm Therapeutic Development Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 2Health News:Muscle Spasm Therapeutic Development Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 3Health News:Muscle Spasm Therapeutic Development Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 4Health News:BPI Sports and Bodybuilding.com Partner Up to Bring an Innovative New Line of Supplements 2Health News:BPI Sports and Bodybuilding.com Partner Up to Bring an Innovative New Line of Supplements 3Health News:Dr. Paul Vitenas Presents at 2015 Aesthetic Meeting 2Health News:Dr. Paul Vitenas Presents at 2015 Aesthetic Meeting 3Health News:Axillary Hyperhidrosis Therapeutic Assessment Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 2Health News:Axillary Hyperhidrosis Therapeutic Assessment Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 3
... Today AXA Equitable,unveiled its new Athena Survivorship ... to deliver cost-effective death benefit,protection to couples and ... needs. By providing a death benefit upon the ... be used to pay sizeable estate,taxes and other ...
... ... Care, STANFORD, ... have donated $150,000 to Lucile,Packard Children,s Hospital at Stanford to expand clinical ... PI is a term that encompasses more than 150 diseases caused ...
... Boston, MAScientists at Schepens Eye Research Institute have ... of tear production are more likely to develop ... situ keratomileusis), laser refractive surgery to correct near- ... Their research, published in the January issue of ...
... ... Processes, NEW ORLEANS, March 3 ... serving science, today launched,significant new technologies at PITTCON 2008 that are designed ... and,applications. PITTCON, the world,s largest conference and exposition for,laboratory science, is under ...
... the FORTUNE ... Survey, MILWAUKEE, March 3 ... 2008 annual survey, FORTUNE,magazine ranked the company as "America,s Most Admired" in the ... have led its industry every year it has been included in,the prestigious survey ...
... , In humans, as in all mammals, ... alternates with dream phases, called Rapid Eye Movement (REM)-sleep. ... memories are consolidated during sleep, this remains a hotly ... help to clarify the function of sleep by revealing ...
Cached Medicine News:Health News:AXA Equitable Meets the Needs of Two People under One Life Insurance Policy 2Health News:AXA Equitable Meets the Needs of Two People under One Life Insurance Policy 3Health News:Jeffrey Modell Foundation and Talecris Biotherapeutics Expand Diagnostic Services for Primary Immunodeficiencies at Lucile Packard Children's Hospital at Stanford 2Health News:Jeffrey Modell Foundation and Talecris Biotherapeutics Expand Diagnostic Services for Primary Immunodeficiencies at Lucile Packard Children's Hospital at Stanford 3Health News:Jeffrey Modell Foundation and Talecris Biotherapeutics Expand Diagnostic Services for Primary Immunodeficiencies at Lucile Packard Children's Hospital at Stanford 4Health News:Scientists discover who is likely to get dry eye syndrome after LASIK surgery 2Health News:Thermo Fisher Scientific Showcases Product Innovation at PITTCON 2008 2Health News:Thermo Fisher Scientific Showcases Product Innovation at PITTCON 2008 3Health News:Thermo Fisher Scientific Showcases Product Innovation at PITTCON 2008 4Health News:Thermo Fisher Scientific Showcases Product Innovation at PITTCON 2008 5Health News:Thermo Fisher Scientific Showcases Product Innovation at PITTCON 2008 6Health News:Northwestern Mutual Is 'America's Most Admired' for an Unprecedented 25th Year 2Health News:'Power napping' in pigeons 2
Qualitative EIA for SS-A, SS-B, Sm, Sm/RNP plus Scl-70 and Jo-1...
... Automation, Inc. (DAI) ENA Profile Enzyme-Linked Immunosorbent ... of antibodies in human serum to individually ... Scl-70 and Jo-1 in a single serum ... to be used as an aid in ...
... This is an enzyme immunoassay(EIA) ... antibodies to extractable nuclear antigens Sm, ... in human serum. The results from ... an aid in the diagnosis of ...
... Screening Kit is designed to screen patient samples ... microtiter well is coated with Sm, RNP, SS-A, ... laboratory to cost effectively screen out the ENA ... specificity on any of the company's other RELISA ...
Medicine Products: